Speciality
Spotlight

       




 


Medicine


   

 




Homocysteinuria

  

  • EK
    Hoogeveen, PJ Kostense., A Jager, et al (Vrije
    Universiteit, Amsterdam)

    Serum
    Homocysteine Level and Protein Intake Are Related to
    Risk of Microalbuminuria: The Hoorn Study
    .

    Kidney
    Int 54: 203-209, 1998.

       

    Both hyperhomocysteinemia and protein intake are
    associated with increased risk of Microalbuminuria
    (MA), independent of non-insulin-dependent diabetes
    mellitus, hypertension, or other known risk factors.
    Hyperhomocysteinemia may be part of the link
    between MA and cardiovascular disease.

          

  • AG
    Bostom, RY Gohh, AJ Beaulieu, et al (Jean Mayer USDA
    Human Nutrition research Ctr, Boston; Rhode Island
    Hosp, Providence; Mem Hosp of Rhode Island,
    Pawtucket)

    Treatment
    of Hyperhomocysteinemia in Renal Transplant
    Recipients: A Randomized, Placebo controlled trial
    .    

    Ann
    Intern Med 127:1089-1092, 1997.

      

    It
    is of interest that plasma homocysteine increases in
    renal transplant recipients even in the presence of
    slight renal impairment.
    This may contribute to an increased risk of
    cardiovascular disease in these individuals.

      

    Administration
    of vitamin B6 decreased homocysteine by 22% and
    folic acid plus vitamin B12 decreased homocysteine
    by 26%.

         

 



 

           

Speciality Spotlight

       

 
Medicine
   

 

Homocysteinuria
  

  • EK Hoogeveen, PJ Kostense., A Jager, et al (Vrije Universiteit, Amsterdam)
    Serum Homocysteine Level and Protein Intake Are Related to Risk of Microalbuminuria: The Hoorn Study
    .
    Kidney Int 54: 203-209, 1998.
       
    Both hyperhomocysteinemia and protein intake are associated with increased risk of Microalbuminuria (MA), independent of non-insulin-dependent diabetes mellitus, hypertension, or other known risk factors. Hyperhomocysteinemia may be part of the link between MA and cardiovascular disease.
          

  • AG Bostom, RY Gohh, AJ Beaulieu, et al (Jean Mayer USDA Human Nutrition research Ctr, Boston; Rhode Island Hosp, Providence; Mem Hosp of Rhode Island, Pawtucket)
    Treatment of Hyperhomocysteinemia in Renal Transplant Recipients: A Randomized, Placebo controlled trial.    
    Ann Intern Med 127:1089-1092, 1997.
      
    It is of interest that plasma homocysteine increases in renal transplant recipients even in the presence of slight renal impairment. This may contribute to an increased risk of cardiovascular disease in these individuals.
      
    Administration of vitamin B6 decreased homocysteine by 22% and folic acid plus vitamin B12 decreased homocysteine by 26%.
         

 

 

By |2022-07-20T16:41:26+00:00July 20, 2022|Uncategorized|Comments Off on Homocysteinuria

About the Author: